Evidence map›Paper›PMID 32072143›Full record

ArticleHemaSphere2020

Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms.

Andrew S Duncombe, Lesley A Anderson, Glen James, Frank de Vocht, Lin Fritschi, Ruben Mesa, Mike Clarke, Mary Frances McMullin

Open access · goldAbstract read
In one paragraph

Article in HemaSphere, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Polycythaemia vera.Nature reviews. Disease primers · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. TheEJHaem · 2023
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Molecular pathogenesis of the myeloproliferative neoplasms.Journal of hematology & oncology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Andrew S DuncombeDepartment of Hematology, University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
Lesley A AndersonCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland.
Glen JamesDepartment of Hematology, University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
Frank de VochtSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Lin FritschiSchool of Public Health, Curtin University, Perth, Western Australia.
Ruben MesaMayo Clinic Cancer Center, Scottsdale/Phoenix, AR.
Mike ClarkeDepartment of Hematology, University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom.
Mary Frances McMullinCentre for Medical Education, Queen's University Belfast, Belfast, Northern Ireland and Belfast Health and Social Care Trust, Northern Ireland.
University Hospital Southampton NHS Foundation Trust · GBCurtin University · AUMayo Clinic in Arizona · USUniversity of Bristol · GB

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
NCI NIH HHS P30 CA054174
6 · The paper itself

Abstract

Despite the identification of acquired genetic mutations associated with Myeloproliferative Neoplasms (MPNs) there is a paucity of information relating to modifiable risk factors that may lead to these mutations. The MOSAICC Study was an exploratory case-control study of polycythemia vera (PV), essential thrombocythemia (ET), and Myelofibrosis (MF). MPN patients and population controls (identified by General Practitioners) and non-blood relative/friend controls were recruited from 2 large UK centers. Participants completed a telephone-based questionnaire analyzed by unconditional logistic regression analysis adjusting for potential confounders. Risk factors for MPNs identified included increasing childhood household density [odds ratio (OR) 2.55, 95% confidence interval (CI) 1.16-5.62], low childhood socioeconomic status (OR 2.30, 95%CI 1.02-5.18) and high pack years smoking (OR 2.19, 95%CI 1.03-4.66) and current smoking restricted to JAK2 positive PV cases (OR 3.73, 95%CI 1.06-13.15). Obesity was linked with ET (OR 2.59, 95%CI 1.02-6.58) confirming results in previous cohort studies. Receipt of multiple CT scans was associated with a strongly increased risk of MPN although with wide confidence intervals (OR 5.38, 95%CI 1.67-17.3). Alcohol intake was inversely associated with risk of PV (OR 0.41, 95%CI 0.19-0.92) and ET (OR 0.48, 95%CI 0.24-0.98). The associations with childhood household density, high pack years smoking and alcohol were also seen in multivariate analysis. This is the largest case control study in MPNs to date and confirms the previously reported associations with obesity and cigarette smoking from cohort studies in addition to novel associations. In particular, the role of smoking and JAK2 mutation cases merits further evaluation.

Identifiers

PMID32072143
PMCPMC7000482
OpenAlexW3005061455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.